VAERS System is Only Recording “Fewer than 1%” of Covid-19 Vaccines Side Effects and DeathsAustin Roe
The Media along with government and medical personnel rave about the accuracy of the Covid-19’s vaccine adversity tracking system known as VAERS, but the truth is that only less than 1% of adverse reactions or death are event reported to VAERS.
Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA). Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger public health. New surveillance methods for drug and vaccine adverse effects are needed. Barriers to reporting include a lack of clinician awareness, uncertainty about when and what to report, as well as the burdens of reporting: reporting is not part of clinicians’ usual workflow, takes time, and is duplicative. Proactive, spontaneous, automated adverse event reporting imbedded within EHRs and other information systems has the potential to speed the identification of problems with new drugs and more careful quantification of the risks of older drugs.
Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation.
If the “pandemic” was as serious as it appeared through the lens of the Media and government entities, there should be more concern for the effectiveness or the safety of these Covid-19 vaccines.
The C.D.C is forced to use a 30-year system for tracking vaccine effectiveness & side effects as the state-of-the-art system called BEST was reported “still in development.” Some doctors are very concerned about the lack of monitoring of these vaccines and their safety for those who get the shot.
“I’m concerned about this disjointed tracking system,” said Dr. Ashish K. Jha, dean of the Brown University School of Public Health. “We knew these vaccines were coming for at least several months before they got authorized, so we really should have had a well-developed system.”
Dr. Jha and others believe that with all the public attention on the vaccines, any serious adverse reactions will likely be reported somewhere. But, they say, a more systematic approach is crucial.
“It’s critical to track, because it will help build confidence,” Dr. Jha said.
Monitoring is all the more important because the vaccines were developed and approved in record time, with the goal of inoculating most of the U.S. population as quickly as possible.
“It’s the right thing to do, but the fact of the matter is we don’t have enough information and we’re desperately in need of post-market information and monitoring,” said a high-ranking F.D.A. official, who asked not to be named because he was not authorized to discuss the matter publicly. – “As Millions Get Shots, F.D.A. Struggles to Get Safety Monitoring System Running” – New York Times
Since VAERS is only reporting less than 1% of the adverse reactions to the Covid-19 vaccines, what are the real numbers?
An article in JAMA reported on anaphylaxis reactions to Covid-19 vaccines, as recorded by the VAERS system from December 14, 2020-January 18, 2021 where out of 1,000,000 doses administered of the Pfizer vaccines 4.7 reported anaphylaxis and of the Moderna vaccines 2.5 were reported.
However, another JAMA article described a vaccine study in March 2021, done by Mass General Brigham (MGB) employees recording the reactions of patients taking their first Covid-19 vaccine dose from 12/16/2020-2/12/2021, with follow-up through 2/18/2021.
Of 64 900 employees who received their first dose of a COVID-19 vaccine, 25 929 (40%) received the Pfizer-BioNTech vaccine and 38 971 (60%) received the Moderna vaccine. At least 1 symptom survey was completed by 52 805 (81%).
The recorded results of anaphylaxis reactions was very different from what was reported by VAERS, and seem to fit what the Harvard medical school study described as a ‘fewer than 1% reported’ of Covid-19 vaccines adverse reactions as recorded by VAERS.
98% did not have any symptoms of an allergic reaction after receiving an mRNA COVID-19 vaccine. The remaining 2% reported some allergic symptoms; however, severe reactions consistent with anaphylaxis occurred at a rate of 2.47 per 10 000 vaccinations. All individuals with anaphylaxis recovered without shock or endotracheal intubation.
Considering we are dealing with vaccines that have bypassed the usual stringent testing and trails previous vaccines have forgone in the past, this is a wildly dangerous system that is not effectively recording the effectiveness or adverse reactions these new vaccines are causing. The truth is we do NOT know what the actual numbers are because the system to record them has been neglected or ceased through lack of funding or incompetence. This small comparison is the only way to even begin to verify the numbers that the VAERS system is producing. If the study by Harvard medical school is correct in estimating that VAERS is recording less than 1% of Covid-19 vaccine side effects and deaths, that the actual number of death could be well over 300,000 in just a few months and could be far worse by the end of 2021.